Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

Clinical trial NCT03907475 · RECRUITING

Trial details

NCT number: NCT03907475
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm

Start date: 2019-07-16
Primary completion: 2027-06-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.